TokenPost topic

Kiniksa Pharmaceuticals

1 TokenPost story is tagged Kiniksa Pharmaceuticals. The newest appear first.

Latest Kiniksa Pharmaceuticals stories

• Kiniksa Raises 2026 ARCALYST Revenue Outlook to $1.045 Billion-$1.050 Billion

  Third-quarter ARCALYST net product revenue was $286 million, up about 58% from a year earlier. Kiniksa expects KPL-387 trial data in the second half of 2027.

  Oct 27, 2026, 9:55 PM EDT · Business